Can We Predict the Grade of Clear Cell Renal Cell Carcinoma from Houns-Field Unit of Renal Lesion on Computerized Tomography Scan, a Retrospective Cross-Sectional Study

References

• Padala SA, Barsouk A, Thandra KC, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79. doi:10.14740/wjon1279
   PubMedGoogle Scholar
• Rossi SH, Klatte T, Usher-Smith J, Stewart GD. Epidemiology and screening for renal cancer. World J Yrol. 2018;36:1341–1353. doi:10.1007/s00345-018-2286-7
   Google Scholar
• Bahadoram S, Davoodi M, Hassanfadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39(3):1.
   Google Scholar
• Low G, Huang G, Fu W, Moloo Z, Girgis S. Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol. 2016;8(5):484. doi:10.4329/wjr.v8.i5.484
   PubMed Web of Science ®Google Scholar
• Bukavina L, Bensalah K, Bray F, et al. Epidemiology of renal cell carcinoma: 2022 update. Europ urol. 2022;82(5):529–542. doi:10.1016/j.eururo.2022.08.019
   PubMed Web of Science ®Google Scholar
• Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387(10021):894–906. doi:10.1016/S0140-6736(15)00046-X
   PubMed Web of Science ®Google Scholar
• Edge SB. Cancer AJCo. AJCC Cancer Staging Manual. Springer; 2010.
   Google Scholar
• Sankineni S, Brown A, Cieciera M, Choyke PL, Turkbey B, editors. Imaging of Renal Cell Carcinoma. Urologic Oncology: Seminars and Original Investigations. Elsevier; 2016.
   Google Scholar
• Deng S-P, Cao S, Huang D-S, Wang Y-P. Identifying stages of kidney renal cell carcinoma by combining gene expression and DNA methylation data. IEEE/ACM Transactions Computational Biol Bioinformatics. 2016;14(5):1147–1153. doi:10.1109/TCBB.2016.2607717
   PubMed Web of Science ®Google Scholar
• Capitanio U, Bedke J, Albiges L, et al. A renewal of the TNM staging system for patients with renal cancer to comply with current decision-making: proposal from the European Association of Urology Guidelines Panel. Europ urol. 2022;S0302-2838(22):02703.
   Google Scholar
• Delahunt B, Eble JN, Egevad L, Samaratunga H. Grading of renal cell carcinoma. Histopathology. 2019;74(1):4–17. doi:10.1111/his.13735
   PubMed Web of Science ®Google Scholar
• Warren AY, Harrison D. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies. World j Urol. 2018;36(12):1913–1926. doi:10.1007/s00345-018-2447-8
   PubMed Web of Science ®Google Scholar
• Pontes O, Oliveira-Pinto S, Baltazar F, Costa M. Renal cell carcinoma therapy: current and new drug candidates. Drug Discovery Today. 2022;27(1):304–314. doi:10.1016/j.drudis.2021.07.009
   PubMed Web of Science ®Google Scholar
• Hounsfield GN. Computed medical imaging. Nobel lecture, December 8, 1979. J Computer Assisted Tomography. 1980;4(5):665–674. doi:10.1097/00004728-198010000-00017
   PubMed Web of Science ®Google Scholar
• Mikhail MI, Singh AK. Von Hippel Lindau Syndrome. Int J Med. 2017.
   Google Scholar
• Ganguly S, Chandra A, Chatterjee IB. Pathobiology of cigarette smoke-induced invasive cancer of the renal pelvis and its prevention by vitamin C. Toxicol Rep. 2018;5:1002–1010. doi:10.1016/j.toxrep.2018.10.005
   PubMedGoogle Scholar
• Kuroda N, Sugawara E, Kusano H, Yuba Y, Yorita K, Takeuchi K. A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects. Pol J Pathol. 2018;69(2):109–113. doi:10.5114/pjp.2018.76693
   PubMed Web of Science ®Google Scholar
• Grünwald V. Risk-adapted (immuno)therapy for renal cell carcinoma. Der Urologe. 2018;57(11):1326–1333. doi:10.1007/s00120-018-0791-3
   Web of Science ®Google Scholar
• Garfield K, LaGrange CA. Renal cell cancer. Hematol Oncol Clin. 2017.
   Google Scholar
• Ward RD, Tanaka H, Campbell SC, Remer EM. 2017 AUA renal mass and localized renal cancer guidelines: imaging implications. Radiographics. 2018;38(7):2021–2033. doi:10.1148/rg.2018180127
   PubMed Web of Science ®Google Scholar
• Lang EK, Hanano A, Rudman E, et al. The fate of small renal masses, less then 1 cm size: outcome study. Int Braz J urol. 2012;38(1):40–48. doi:10.1590/S1677-55382012000100006
   PubMed Web of Science ®Google Scholar
• Liaw CW, Winoker JS, Mehrazin R. Imaging protocols for active surveillance in renal cell carcinoma. Curr Urol Reports. 2018;19(10):1–7. doi:10.1007/s11934-018-0830-z
   PubMed Web of Science ®Google Scholar
• Herts BR, Coll DM, Novick AC, et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. Am J Roentgenol. 2002;178(2):367–372. doi:10.2214/ajr.178.2.1780367
   PubMed Web of Science ®Google Scholar
• Dilauro M, Quon M, McInnes M, et al. Comparison of contrast-enhanced multiphase renal protocol CT versus MRI for diagnosis of papillary renal cell carcinoma. AJR Am J Roentgenol. 2016;206(2):319–325. doi:10.2214/AJR.15.14932
   PubMed Web of Science ®Google Scholar
• Schieda N, Vakili M, Dilauro M, Hodgdon T, Flood TA, Shabana WM. Solid renal cell carcinoma measuring water attenuation (− 10 to 20 HU) on unenhanced CT. Am J Roentgenol. 2015;205(6):1215–1221. doi:10.2214/AJR.15.14554
   PubMed Web of Science ®Google Scholar
• Wu Z, Ouyang C, Peng L. An immune scores-based nomogram for predicting overall survival in patients with clear cell renal cell carcinoma. Medicine. 2020;99(34):e21693. doi:10.1097/MD.0000000000021693
   PubMed Web of Science ®Google Scholar
• Elmore JM, Kadesky KT, Koeneman KS, Sagalowsky AI. Reassessment of the 1997 TNM classification system for renal cell carcinoma: a 5‐cm T1/T2 cutoff is a better predictor of clinical outcome. Cancer. 2003;98(11):2329–2334. doi:10.1002/cncr.11806
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999;17(8):2530–2540. doi:10.1200/JCO.1999.17.8.2530
   PubMed Web of Science ®Google Scholar
• Mekhail TM, Abou-Jawde RM, BouMerhi G, et al. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. J Clin Oncol. 2005;23(4):832–841. doi:10.1200/JCO.2005.05.179
   PubMed Web of Science ®Google Scholar
• Jonasch E. Updates to the management of kidney cancer. J National Compr Cancer Network. 2018;16(5S):639–641. doi:10.6004/jnccn.2018.0039
   PubMedGoogle Scholar
• Dabestani S, Marconi L, Kuusk T, Bex A. Follow-up after curative treatment of localised renal cell carcinoma. World j Urol. 2018;36(12):1953–1959. doi:10.1007/s00345-018-2338-z
   PubMed Web of Science ®Google Scholar